The media company Morning Consult reports that Democrats on the House Energy and Commerce Committee have sent a letter to the beleagured blood testing company Theranos, scrutinizing the company's policies, and demanding an explanation by July 14th of what the company is doing to address its "failures."
"Given Theranos' disregard for patient safety and its failure to immediately address concerns by federal regulators," says the letter from New Jersey Democrat Frank Pallone, Jr. and two others, "we write to request more information about how company policies permitted systematic violations of federal law ...."
Morning Consult reports:
They request that the company brief committee staff on how Theranos is working with regulators to bring its California laboratory into compliance, how it will prevent future compliance issues, whether the company is conducting an internal investigation and how the company is working with medical providers and patients that could have been harmed.
Theranos sent this written reply: "We are proud of the work we have done, and look forward to answering the members’ questions and explaining the significant actions we have taken with new operational leadership and quality standards at our laboratories. We are committed to the highest standards of excellence across all our labs and look forward to continuing constructive engagement with our regulators ...."